Cardiologists at the Heart Hospital at Northwest Texas Healthcare System conducted their 100th procedure at the hospital using Impella®, the world’s smallest heart pump. Designed to provide minimally-invasive, temporary support for patients with heart failure, technology like Impella will allow Northwest to provide more comprehensive and advanced care options to patients in the Panhandle with advanced coronary disease. Impella allows patients' hearts to recover, which can result in better quality of life. It also has the potential to increase efficiencies within the cardiology healthcare sector.
Impella is the only FDA-approved percutaneous hemodynamic support device determined to be safe and effective for the treatment of elective and emergent high risk patients, and recently received expanded approval from the United States Food and Drug Administration (FDA).
The Impella device is placed into the heart through a peripheral artery and will support the heart circulatory system during an elective high-risk percutaneous coronary intervention (PCI) procedure, called Protected PCI. It is also approved to treat cardiogenic shock, a condition where the heart fails to pump enough blood to vital organs and they begin to shut down. Cardiogenic shock typically happens during or after a heart attack.